Hepatitis C virus treatment update - A new era of all-oral HCV treatment

Summary There are estimated to be more than a hundred million hepatitis C virus (HCV) carriers worldwide. About 30% of carriers develop serious liver diseases, such as liver cirrhosis and hepatocellular carcinoma. HCV Genotype 1 is the most common genotype worldwide and the most difficult to treat with interferon‐based therapy. Therapy for patients with chronic HCV infection is complicated by poor tolerability and inadequate rates of sustained...